Cargando…

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270929/ https://www.ncbi.nlm.nih.gov/pubmed/32547649 http://dx.doi.org/10.1177/1758835920932317

Ejemplares similares

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
por: Barni, Sandro, et al.
Publicado: (2020)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
por: Piver, Rachael N., et al.
Publicado: (2023)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
por: Sobrero, A, et al.
Publicado: (2005)

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
por: Rupa-Matysek, Joanna, et al.
Publicado: (2017)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum]
Publicado: (2022)

Tosca
por: Puccini, Giacomo, 1858-1924
Publicado: (1993)

Tosca
por: Puccini, Giacomo, 1858-1924
Publicado: (1990)

Tosca /
por: Puccini, Giacomo, 1858-1924
Publicado: (1991)

Tosca
Publicado: (1986)

Tosca
por: Puccini, Giacomo, 1858-1924
Publicado: (1991)

Tosca
por: Puccini, Giacomo, 1858-1924
Publicado: (1992)

Polyethylenimine-based micro/nanoparticles as vaccine adjuvants [Corrigendum]
Publicado: (2017)

Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
por: Austin, Keziah, et al.
Publicado: (2019)

Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
por: Ramos-Esquivel, Allan, et al.
Publicado: (2022)

c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Publicado: (2019)

Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
por: Golan, Yoav, et al.
Publicado: (2021)

Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids [Corrigendum]
Publicado: (2015)

Marked Reduction in 28-Day Mortality Among Elderly Patients with Severe Community-Acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial [Corrigendum]
Publicado: (2020)

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
Publicado: (2021)

Tosca : melodramma in 3 atti
por: Puccini, Giacomo, 1858-1924
Publicado: (1954)

Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience
por: Ahmed, Gulrayz, et al.
Publicado: (2020)

Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry
por: Ohashi, Yasuo, et al.
Publicado: (2020)

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
por: Ruzzo, Annamaria, et al.
Publicado: (2014)

Corrigendum to Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
Publicado: (2023)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Funding information of the article entitled “Post-hoc simulation study of computerized adaptive testing for the Korean Medical Licensing Examination”
por: Seo, Dong Gi, et al.
Publicado: (2018)

Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
por: Moreno-García, E, et al.
Publicado: (2022)

Corrigendum to “Correction of a Class III Malocclusion with a Functional Shift and Severe Crowding”
por: Alogaibi, Yahya A., et al.
Publicado: (2021)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
Publicado: (2019)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
Publicado: (2018)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

Corrigendum to “Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund's Adjuvant”
por: Lee, Jong-Uk, et al.
Publicado: (2021)

Corrigendum to “Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma”
por: Luo, Qizhan, et al.
Publicado: (2021)

Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer [Corrigendum]
Publicado: (2021)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hpe7q438q0rnajqbc2dgb9f03h